Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|December 16, 2004
Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transportA R Buursma, I J van Dillen, A van Waarde, et al.
British Journal of Cancer|April 1, 1995
Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell linesM W Sark, H Timmer-Bosscha, C Meijer, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1985
Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6)J J Offerman, S Meijer, N H Mulder, et al.
International Journal of Cancer|March 10, 2000
Role of metallothionein in cisplatin sensitivity of germ-cell tumoursC Meijer, A Timmer, E G De Vries, et al.
Cancer Treatment Reports|June 1, 1987
Pharmacokinetics of high-dose teniposideJ J Holthuis, L G de Vries, P E Postmus, et al.
The Netherlands Journal of Medicine|April 1, 1989
Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumoursP O Mulder, P Schröder, H G de Vries-Hospers, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin BC P Schröder, E G de Vries, N H Mulder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Clinical pharmacokinetics of (NPAz2)2NSOAz: 'SOAz'S Rodenhuis, A H Scaf, N H Mulder, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancerE G De Vries, A G Nanninga, J Greidanus, et al.
European Journal of Cancer|June 1, 1980
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tractD T Sleijfer, N H Mulder, H G de Vries-Hospers, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|December 16, 2004
Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transportA R Buursma, I J van Dillen, A van Waarde, et al.
British Journal of Cancer|April 1, 1995
Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell linesM W Sark, H Timmer-Bosscha, C Meijer, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1985
Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6)J J Offerman, S Meijer, N H Mulder, et al.
International Journal of Cancer|March 10, 2000
Role of metallothionein in cisplatin sensitivity of germ-cell tumoursC Meijer, A Timmer, E G De Vries, et al.
Cancer Treatment Reports|June 1, 1987
Pharmacokinetics of high-dose teniposideJ J Holthuis, L G de Vries, P E Postmus, et al.
The Netherlands Journal of Medicine|April 1, 1989
Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumoursP O Mulder, P Schröder, H G de Vries-Hospers, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin BC P Schröder, E G de Vries, N H Mulder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Clinical pharmacokinetics of (NPAz2)2NSOAz: 'SOAz'S Rodenhuis, A H Scaf, N H Mulder, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancerE G De Vries, A G Nanninga, J Greidanus, et al.
European Journal of Cancer|June 1, 1980
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tractD T Sleijfer, N H Mulder, H G de Vries-Hospers, et al.
Pageof 37